MedPath

MYOBLOC

MYOBLOC

Discontinued
DIN Number

02252295

Drug Class

Human

Market Date

N/A

Company
HC

solstice neurosciences, llc, a subsidiary of mdd us operations, llc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02252295
AIG Number0150061001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
M03AX01 BOTULINUM TOXIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification12:20.20.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

RIMABOTULINUMTOXINBActive
Strength: 5000 UNIT / ML
Monograph: RIMABOTULINUMTOXINB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.